Connection

Shikhar Mehrotra to NAD

Back to Details
This is a "connection" page, showing publications Shikhar Mehrotra has written about NAD.
Shikhar Mehrotra
Connection Strength
1.406
NAD
  1. CD38-NAD+-Sirt1 axis in T cell immunotherapy. Aging (Albany NY). 2019 10 23; 11(20):8743-8744.
    View in: PubMed
    Score: 0.641
  2. CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response. Cell Metab. 2018 01 09; 27(1):85-100.e8.
    View in: PubMed
    Score: 0.559
  3. CD38: Modulating Histone Methyltransferase EZH2 Activity in SLE. Trends Immunol. 2020 03; 41(3):187-189.
    View in: PubMed
    Score: 0.164
  4. CD38: T Cell Immuno-Metabolic Modulator. Cells. 2020 07 17; 9(7).
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.